SCOTTSDALE, Ariz.--(BUSINESS WIRE)--June 15, 2005--Holmes Herbs, Inc. (OTCBB:HMHB) announced today that it has signed a letter of intent to acquire the assets of a clinical drug research and development business from Qualia Clinical Research Services Inc. (“Qualia”). Qualia provides clinical research, Phase I, II, III, & IV human drug trials, on behalf of established pharmaceutical companies. Holmes intends to fund the expansion of Qualia’s business plan to include a larger clinical research business, plus drug development.
